Antiviral prophylaxis in patients with solid tumours and haematological malignancies—update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)

Reactivation of viral infections is common in patients with solid tumour or haematological malignancy. Incidence and severity depend on the extent of cellular immunosuppression. Antiviral prophylaxis may be effective to prevent viral reactivation. In 2006, the Infectious Diseases Working Party of Ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandherr, Michael, Hentrich, Marcus, von Lilienfeld-Toal, Marie, Massenkeil, Gero, Neumann, Silke, Penack, Olaf, Biehl, Lena, Cornely, Oliver A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525190/
https://www.ncbi.nlm.nih.gov/pubmed/26193852
http://dx.doi.org/10.1007/s00277-015-2447-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525190/
https://www.ncbi.nlm.nih.gov/pubmed/26193852
http://dx.doi.org/10.1007/s00277-015-2447-3

Ejemplares similares